News & Blogs

Seniors Paid Billions in Extra Premiums Due to Alleged Medicare Overpayments

The average American senior’s Medicare premiums last year were about 10% higher, or more than $200 annually, because of alleged overpayments to private Medicare Advantage plans, congressional investigators found. Medicare Part B premiums that most seniors pay were partly pushed up by controversial health-insurer practices such as adding diagnoses to trigger higher payments, according to the Joint Economic Committee, a bipartisan group of lawmakers that advises Congress on financial matters.

Learn More

Commitment to Seniors Applauds President Trump’s Call to Rein in Big Insurers, Warns Against Efforts to Codify “Most Favored Nation”

Washington, D.C. – February 25, 2026 – Commitment to Seniors, a project of American Commitment, applauds President Trump for addressing abusive insurer practices and urging lawmakers to rein in rising health care costs during last night’s State of the Union. However, we strongly oppose any effort to codify the administration’s Most Favored Nation (MFN) drug pricing proposal into law. By tying U.S. reimbursement rates to prices set by socialist-style foreign governments, MFN would undermine the…

Learn More

2025: Big Insurance’s $1.7 Trillion Year

In 2025, the seven biggest health insurance conglomerates: Collected almost $1.7 trillion in total revenues, $175 billion more than in 2024; Made more than $54 billion in profits; Covered 10 million fewer people than in 2024; Ramped up their self-dealing by steering more of their health plan enrollees to physician practices, clinics, pharmacy operations and other clinical businesses they now own

Learn More

Big government and big insurance win while patients lose

Congress finally hauled the nation’s insurance giants to Capitol Hill to explain why their profits have skyrocketed at taxpayer expense while their approval ratings with the American people have plummeted. The hearings were a necessary first step, but asking CEOs tough questions is a lot easier than passing policy reforms that would diminish their power and ability to capture vast sums of taxpayer dollars — that will take hard work. For the better part of two decades now, Democrats who once wanted…

Learn More

Affordability Requires Supply, Not Price Controls

With the 2026 midterms approaching, there is an understandable desire on Capitol Hill to “do something.” But lawmakers should resist the temptation to reach for easy answers such as government-imposed price controls. Price controls are not market reforms. They are administrative attempts to override prices rather than address the conditions that make goods and services unaffordable in the first place. History shows that when government tries to control prices instead of expanding supply, the results…

Learn More

Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices

The spending package passed by Congress on Tuesday includes an effort to drive down drug prices, by imposing new restrictions on some of the most controversial practices of the giant companies that oversee prescription benefits. The legislation represents a significant political defeat for the companies, known as pharmacy benefit managers, or P.B.M.s, which for years had largely escaped public attention, regulation and oversight. And it represents a win for drugmakers, which have long lobbied to deflect…

Learn More

Siding with health care insurers emerges as political liability in 2026 midterm elections

As a pollster, I have learned to listen closely when voters speak with clarity. On health care costs, voters in battleground congressional districts are speaking louder than ever. They do not like what Democrats have delivered over the past 15 years on health care, and they are increasingly supportive of the reforms being advanced by President Trump and Republicans in Congress. This is a real political shift. In a January survey of 1,000 likely voters in battleground…

Learn More

Big Insurance CEO Hearings: 5 Clips to Watch

Last week, the U.S. House Energy and Commerce and Ways and Means Committees summoned five of the most powerful executives in the American health insurance industry to answer for their outsized roles in the U.S.-health ecosystem. And how their roles are leaving Americans increasingly sicker and poorer while they turn a profit. For starters, let’s take a moment to acknowledge that the hearing was unprecedented. Even in the days leading to the passage of the…

Learn More